Effects of Endothelin-1 on Hepatic Blood Flow
Author Information
Author(s): Kjetil Unneberg, Marianne Mjaaland, Elin Helseth, Arthur Revhaug
Primary Institution: University Hospital of Tromos, Norway
Hypothesis
This study was designed to compare the effects of endothelin-1 on hepatic blood flow after central venous and intraportal injection.
Conclusion
Central venous injection of endothelin-1 causes a larger decrease in portal vein flow and a smaller increase in portal vein pressure than intraportal injection.
Supporting Evidence
- Central venous injection caused a larger reduction in portal vein flow.
- Intraportal injection caused a larger increase in portal vein pressure.
- Repeated injections resulted in a reduction in portal vein flow and an increase in portal vein vascular resistance.
Takeaway
The way we give a substance called endothelin-1 affects how blood flows in the liver; injecting it through a vein has a different effect than injecting it directly into the liver.
Methodology
The study involved six piglets that received bolus injections of endothelin-1 through central venous and intraportal routes, with continuous monitoring of blood flow and pressure.
Limitations
Technical difficulties led to missing data for renal artery flow in one animal.
Participant Demographics
Six Norwegian Landrace piglets weighing between 24 and 27 kg.
Statistical Information
P-Value
p .003
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website